FilippiMRoccaMABarkhofF. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol2012;11:349–60.
2.
FisnikuLKBrexPAAltmannDR. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain2008;131:808–17.
3.
SormaniMPArnoldDLDe StefanoN. Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis. Ann Neurol2014;75:43–9.
4.
BermelRAYouXFouldsP. Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta. Ann Neurol2013;73:95–103.
5.
GoodinDSTraboulseeAKnappertzV. Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon beta-1b trial in multiple sclerosis. J Neurol Neurosurg Psychiatry2012;83:282–7.
6.
DobsonRRudickRATurnerBSchmiererKGiovannoniG. Assessing treatment response to interferon-beta: is there a role for MRI?Neurology2014;82:248–54.
7.
SormaniMPRioJTintoreM. Scoring treatment response in patients with relapsing multiple sclerosis. Mult Scler2013;19:605–12.
8.
RioJCastilloJRoviraA. Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler2009;15:848–53.
9.
Erbayat AltayEFisherEJonesSEHara-CleaverCLeeJCRudickRA. Reliability of classifying multiple sclerosis disease activity using magnetic resonance imaging in a multiple sclerosis clinic. JAMA Neurol2013;70:338–44.
10.
BanwellBGiovannoniGHawkesCLublinF. Editors’ welcome and a working definition for a multiple sclerosis cure. Multiple Sclerosis and Related Disorders2013;2:65–7.
11.
TuohyOCostelloeLHill-CawthorneG. Alem-tuzumab treatment of multiple sclerosis: long-term safety and efficacy. J Neurol Neurosurg Psychiatry2014.
12.
VrenkenHJenkinsonMHorsfieldMA. Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol2013;260:2458–71.
13.
FelsonDTSmolenJSWellsG. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum2011;63:573–86.
